Table 1. Demographics and Clinical Characteristics.
Comparison of demographic and clinical characteristics between AT1R-Ab positive and negative patients. IQR, interquartile range; ESRD, end stage renal disease; FSGS, focal segmental glomerulosclerosis; PKD, polycystic kidney disease; EBV, Epstein-Barr virus; CMV, cytomegalovirus; BKV, BK virus
| AT1R-Ab Positive (n=38) |
AT1R-Ab Negative (n=27) |
p-value | |
|---|---|---|---|
| Age, median (IQR) | 14.8 (12.8–17.6) | 16.4 (13.3–18.4) | 0.369 |
| Male Sex | 23 (60.5%) | 16 (59.3%) | >0.99 |
| Hispanic Ethnicity | 18 (47.4%) | 18 (66.7%) | 0.138 |
| Race | 0.243 | ||
| White | 28 (73.7%) | 19 (70.4%) | |
| Asian | 2 (5.3%) | 2 (7.4%) | |
| Black | 4 (10.5%) | 0 (0%) | |
| Other | 4 (10.5%) | 6 (22.2%) | |
| Dialysis Prior to Transplant | 32 (84.2%) | 19 (70.4%) | 0.227 |
| Years on Dialysis, median (IQR) | 2.4 (0.8–3.1) | 1.7 (1.1–2.5) | 0.355 |
| EBV Immune | 28 (73.7%) | 20 (74.1%) | >0.99 |
| CMV Immune | 24 (63.2%) | 14 (51.9%) | 0.446 |
| Deceased Donor | 26 (68.4%) | 14 (51.9%) | 0.204 |
| Etiology of ESRD | 0.931 | ||
| Dysplasia | 5 (13.2%) | 4 (14.8%) | |
| FSGS | 6 (15.8%) | 3 (11.1%) | |
| Glomerulonephritis | 5 (13.2%) | 3 (11.1%) | |
| IgA nephropathy | 0 (0%) | 1 (3.7%) | |
| Obstructive Uropathy | 9 (23.7%) | 7 (25.9%) | |
| PKD | 2 (5.3%) | 0 (0%) | |
| Other | 5 (13.2%) | 5 (18.5%) | |
| Unknown | 6 (15.8%) | 4 (14.8%) | |
| Cold Ischemia Time (hours), median (IQR) | 11.1 (1–13.8) | 6.3 (1–15) | 0.447 |
| Delayed Graft Function | 3 (7.9%) | 1 (3.7%) | 0.636 |
| EBV, CMV, or BK Viremia | 18 (52.9%) | 11 (44%) | 0.601 |
| Physician Assessed Non - Adherence | 11 (28.9%) | 5 (18.5%) | 0.393 |